Skip to Content

Bioelectronics Corp BIEL

Morningstar Rating
$0.00 0.00 (25.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BIEL is trading at a 40% discount.
Price
$0.00
Fair Value
$6.13
Uncertainty
Extreme
1-Star Price
$6.32
5-Star Price
$5.76
Economic Moat
Rcmv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BIEL is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$6.18 Mil
Volume/Avg
3.6 Mil / 26.2 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Bioelectronics Corp is an electroceutical company. The company develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its product line includes Actipatch Musculoskeletal Pain Therapy, Allay menstrual pain therapy, Smart insole heel pain therapy and Recovery RX post operative and Chronic wounds therapy. It sells its products to wholesale distributors, directly to hospitals and clinics, and consumers.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Total Number of Employees

Valuation

Metric
BIEL
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
BIEL
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
BIEL
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesKnlxfjplRcqvyx$183.8 Bil
SYK
Stryker CorpGrvlwvdryKmsfb$127.8 Bil
MDT
Medtronic PLCHzslnhkxsCqqrms$105.0 Bil
BSX
Boston Scientific CorpPzgfvngxbBfngdb$99.9 Bil
EW
Edwards Lifesciences CorpXnnwwpwtmMjyns$52.5 Bil
DXCM
DexCom IncVzwfvbfkhBvjhl$51.9 Bil
ZBH
Zimmer Biomet Holdings IncFmmblvrzYpy$24.9 Bil
ALGN
Align Technology IncTvrzyyzklFgrjb$22.6 Bil
PHG
Koninklijke Philips NV ADRPjkrphfzRqddnjq$18.2 Bil
PODD
Insulet CorpYvxlkffrWtttvc$11.6 Bil

Sponsor Center